|
|
Post by mannmade on Apr 23, 2018 17:40:40 GMT -5
Site actually looks pretty nice on mobile. Also seems to have a more clear and direct message about why (advantages) and how to use. Much better imho.
|
|
|
|
Post by goyocafe on Apr 23, 2018 18:43:47 GMT -5
At first glance, and a quick one at that, looks great. A couple of gotcha's though, they rolled it out without having the search fields coded correctly on "Find a Doctor" and also the "Blog" page. Find a doctor is the big one here though. Hopefully they know about this. I'll look around to see where to contact webmaster unless someone here knows the contact. I think they could take some queues from the Fiasp website. Fiasp websiteMy overall impression is that they are still focusing most of the attention on the fact that Afrezza is inhalable. I was hoping when the new site came out that it would be more focused on Afrezza's time of action. When I looked at the Fiasp site, I got it, it's faster (even if only by a matter of minutes). Message received. Look at this page: www.fiasppro.com/the-fiasp-story/onset-of-appearance.htmlIt messes with my mind that they can talk about "appearance in the bloodstream" in the same context as glucose lowering effect. Where's Mannkind's page specifically dealing with fast onset (fast on AND fast off)? When I look at the Afrezza website, the take away is that it's inhaled. I really think it should be secondary, not burried mind you, just not the main focus. Put the absorption cure on the front page that shows the fast spike (quick in, quick out, no tail) attributes of the drug. |
|
|
|
Post by digger on Apr 23, 2018 19:28:55 GMT -5
I think they could take some queues from the Fiasp website. Fiasp websiteMy overall impression is that they are still focusing most of the attention on the fact that Afrezza is inhalable. I was hoping when the new site came out that it would be more focused on Afrezza's time of action. When I looked at the Fiasp site, I got it, it's faster (even if only by a matter of minutes). Message received. Look at this page: www.fiasppro.com/the-fiasp-story/onset-of-appearance.htmlIt messes with my mind that they can talk about "appearance in the bloodstream" in the same context as glucose lowering effect. Where's Mannkind's page specifically dealing with fast onset (fast on AND fast off)? When I look at the Afrezza website, the take away is that it's inhaled. I really think it should be secondary, not burried mind you, just not the main focus. Put the absorption cure on the front page that shows the fast spike (quick in, quick out, no tail) attributes of the drug. I agree. What's the first thing you see on www.fiasppro.com -- "Fiasp is a familiar and fast‑acting mealtime insulin" so the viewer immediately knows this isn't some weird "ide" or "one," but just a variation on old familiar lispro. Then the viewer sees an apple with a bite taken out of it sitting next to a stopwatch and labeled "with the first bite." Then comes "No more waiting to eat. Fiasp® can be taken at the start of a meal, or within 20 minutes of starting." A few more details come after that but in those few lines the viewer already has most of the information that's relevant. Also note that at the bottom of the page is a very subtle "Selected Important Safety Information" followed by a brief "contraindications" and "warnings and precautions." To see any more, you have to click on "show more." Compare that to afrezza's: "Important Safety Information for Afrezza (insulin human) Inhalation Powder [in bright orange no less] What is the most important information I should know about Afrezza? Afrezza can cause serious side effects, including: Sudden lung problems (bronchospasms). Do not use Afrezza if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting Afrezza, your healthcare provider will give you a breathing test to check how your lungs are working." They couldn't present it a little more understated and maybe save the details for the bottom of the page with the rest of the safety data? And this needs to be changed or eliminated -- "Once Afrezza leaves your system it doesn't continue to lower your blood sugar." That should be pretty obvious. |
|
|
|
Post by sportsrancho on Apr 23, 2018 20:10:59 GMT -5
Rick:
$MNKD Relaunch Of Afrezza.com is Now Underway! What an IMPROVEMENT! What an IMPROVEMENT!
Testimonials will Soon be a Part of this New Site! Bullish
|
|
|
|
Post by tiberious on Apr 23, 2018 21:09:28 GMT -5
Happy they took the suggestion of showing someone inhaling on the front screen! Finally!
|
|
|
|
Post by tiberious on Apr 23, 2018 21:15:34 GMT -5
I think they could take some queues from the Fiasp website. Fiasp websiteMy overall impression is that they are still focusing most of the attention on the fact that Afrezza is inhalable. I was hoping when the new site came out that it would be more focused on Afrezza's time of action. When I looked at the Fiasp site, I got it, it's faster (even if only by a matter of minutes). Message received. Look at this page: www.fiasppro.com/the-fiasp-story/onset-of-appearance.htmlIt messes with my mind that they can talk about "appearance in the bloodstream" in the same context as glucose lowering effect. Where's Mannkind's page specifically dealing with fast onset (fast on AND fast off)? When I look at the Afrezza website, the take away is that it's inhaled. I really think it should be secondary, not burried mind you, just not the main focus. Put the absorption cure on the front page that shows the fast spike (quick in, quick out, no tail) attributes of the drug. Disagree, the initial take away should be that it is inhaled, followed by the science. You don't sell the steak... you sell the si zzle of Afre zza. |
|
|
|
Post by mannmade on Apr 23, 2018 21:59:36 GMT -5
It appears to be they are using the inhaled aspect to talk more about how fast that enables the insluin to enter the blood thru the lungs and less needles are secondary to the inhaled apsect now.
A better reason to use inhaled over RAA's imho for anyone questioning why would use inhaled. However athough they also talk about how it lowers bg fast, what they need to do imho is make the direct connection to better control as a result with less hyerglycemic, and more Time in range which then equals less long term side effects.
They say all of the above or imply it to some degree, but not in a direct enough manner (eg: 2 + 2 = 4) to truly sell the real benefits without having to figure it out. First timers may not see the connection as many here do or those who have been using it for a while.
|
|
|
|
Post by mango on Apr 23, 2018 22:28:06 GMT -5
The yellow/gold is harsh not an attractor. When I read through the site I am engaged only when there is a purple or white background because purple and white are attractors and easy on the eyes, (text is more engaging with those background compared to gold/yellow), borders and fonts, etc...are more simplified for the brain to handle and are more pleasant easy on eyes. Yellow/gold is harsh and not easy on the eyes and the valuable and important info is contained in the gold/yellow backdrop sections and it honestly is a burden to read this way. Yellow/gold is not an attractor.
Otherwise I love the site.
No offense btw just shooting my opinion.
|
|
|
|
Post by mnholdem on Apr 24, 2018 4:56:37 GMT -5
Looks great to me. I do think they should add the word "Menu" next to the menu symbol at the upper-right, though (mobile version for iPad). Not everybody is computer/web-savvy. One of the menu items enables readers to go to the Afrezza HCP site. That site still retains its original format and I suspect that MannKind will be upgrading that site soon. I hope it will included better updated (STAT) titration instructions.  |
|
|
|
Post by #NoMoreNeedles on Apr 24, 2018 4:57:22 GMT -5
New Afrezza website powered by mannkind.activehosted.com/admin/ > ActiveCampaign and Brightcove video marketing. You can see that when using Chrome developer tools. |
|
|
|
Post by mnholdem on Apr 24, 2018 5:31:26 GMT -5
Site actually looks pretty nice on mobile. Also seems to have a more clear and direct message about why (advantages) and how to use. Much better imho. Although the site seems to work fine on my iPad, I cannot view the site's main pages on my older iPhone-4S. The Safety Information completely fills the screen no matter what page I navigate to from the menu and the site won't let me minimize the safety information. I'm hoping they'll have that glitch fixed quickly.  |
|
|
|
Post by cjm18 on Apr 29, 2018 9:48:28 GMT -5
|
|
|
|
Post by peppy on Apr 29, 2018 10:48:14 GMT -5
|
|
|
|
Post by cjm18 on Apr 29, 2018 11:14:39 GMT -5
Both of the hypo and a1c studies (afrezza is worse) are still on the prescribing info. Only 30 patients in the study that changed the label. !!!! Stat study has 30 in each arm (60 total). |
|
